Heron Therapeutics Files 8-K: Officer Changes & Exhibits
Ticker: HRTX · Form: 8-K · Filed: 2026-04-06T08:30:11-04:00
Sentiment: neutral
Topics: officer-change, filing, exhibit
Related Tickers: HRTX
TL;DR
Heron Therapeutics (HRTX) filed an 8-K detailing officer changes and compensation. Keep an eye on leadership stability.
AI Summary
Heron Therapeutics, Inc. filed an 8-K on April 6, 2026, reporting on the departure of a director and the appointment of a new officer. The filing also includes details on compensatory arrangements for certain officers and financial statements/exhibits.
Why It Matters
This filing indicates potential shifts in the company's leadership and provides updated financial and compensatory information, which could influence investor perception.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting routine changes and disclosures, not indicating immediate operational or financial distress.
Key Numbers
- 85085 — 8-K iXBRL Document Size (Size of the main 8-K filing document in bytes.)
- 161955 — EX-10.1 Document Size (Size of Exhibit 10.1 in bytes.)
Key Players & Entities
- Heron Therapeutics, Inc. (company) — Filer of the 8-K report
- 0000818033 (company) — CIK number for Heron Therapeutics, Inc.
- 2026-04-06 (date) — Filing date of the 8-K
- 2026-04-03 (date) — Period of report for the 8-K
FAQ
Who departed from Heron Therapeutics, Inc. as reported in Item 5.02?
The filing indicates the departure of a director, though the specific name is not detailed in the provided text.
What is the filing date of this 8-K report?
The 8-K report was filed on April 6, 2026.
What is the business address of Heron Therapeutics, Inc.?
The business address is 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO CA 92121.
What are the main items covered in this 8-K filing?
The main items covered are Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits).
What is the CIK number for Heron Therapeutics, Inc.?
The CIK number for Heron Therapeutics, Inc. is 0000818033.
From the Filing
EDGAR Filing Documents for 0001193125-26-142947 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001193125-26-142947 Filing Date 2026-04-06 Accepted 2026-04-06 08:30:11 Documents 13 Period of Report 2026-04-03 Items Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 8-K hrtx-20260403.htm iXBRL 8-K 85085 2 EX-10.1 hrtx-ex10_1.htm EX-10.1 161955 3 EX-10.2 hrtx-ex10_2.htm EX-10.2 122795 4 EX-10.3 hrtx-ex10_3.htm EX-10.3 127749 5 EX-10.4 hrtx-ex10_4.htm EX-10.4 127939 Complete submission text file 0001193125-26-142947.txt 864388 Data Files Seq Description Document Type Size 6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hrtx-20260403.xsd EX-101.SCH 49738 16 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-20260403_htm.xml XML 4711 Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400 HERON THERAPEUTICS, INC. /DE/ (Filer) CIK : 0000818033 (see all company filings) EIN. : 942875566 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 26839644 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)